This list is based on the watchlists of people on Stock Events who follow GCTK. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
FAQs
What is GlucoTrack stock price today?▼
The current price of GCTK is $0.81 USD — it has decreased by -41.73% in the past 24 hours. Watch GlucoTrack stock price performance more closely on the chart.
What is GlucoTrack stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange GlucoTrack stocks are traded under the ticker GCTK.
What is GlucoTrack market cap?▼
Today GlucoTrack has the market capitalization of 959,135.58
What were GlucoTrack earnings last quarter?▼
GCTK earnings for the last quarter are -0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GlucoTrack revenue for the last year?▼
GlucoTrack revenue for the last year amounts to 0 USD.
What is GlucoTrack net income for the last year?▼
GCTK net income for the last year is -19.39M USD.
How many employees does GlucoTrack have?▼
As of November 2, 2026, the company has 15 employees.
In which sector is GlucoTrack located?▼
GlucoTrack operates in the Health & Wellness sector.
When did GlucoTrack complete a stock split?▼
The last stock split for GlucoTrack was on October 26, 2026 with a ratio of 1:2.
Where is GlucoTrack headquartered?▼
GlucoTrack is headquartered in RUTHERFORD, United States.